As of December 13 at 4:00:00 PM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-8,837.1960
-10,544.8700
-15,292.2970
-5,581.0220
-3,431.8680
Investing Cash Flow
-27.6440
-208.7890
-310.1970
-143.2240
-204.9930
Financing Cash Flow
8,062.8150
8,520.3760
18,653.2140
6,525.1380
3,430.2720
End Cash Position
1,116.4970
2,462.6090
4,808.0600
1,566.6880
748.0150
Capital Expenditure
-27.6440
-208.7890
-365.1970
-143.2240
-204.9930
Issuance of Capital Stock
2,764.9680
4,186.8620
3,369.8770
285.1080
3,898.8180
Issuance of Debt
--
--
18.1100
6,383.6590
--
Repayment of Debt
--
--
-2,632.3240
-122.4690
-415.2730
Free Cash Flow
-8,864.8400
-10,753.6590
-15,657.4940
-5,724.2460
-3,636.8610
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PTIXW Protagenic Therapeutics, Inc.
0.0140
0.00%
ATNFW 180 Life Sciences Corp.
0.0083
+1.22%
TVGNW Tevogen Bio Holdings Inc.
0.0420
0.00%
NAMSW NewAmsterdam Pharma Company N.V.
13.48
+0.60%
UPB Upstream Bio, Inc.
19.98
-1.33%
CDIOW Cardio Diagnostics Holdings, Inc.
0.1301
+27.55%
ARMP Armata Pharmaceuticals, Inc.
2.2000
+0.37%
CEROW CERo Therapeutics Holdings, Inc.
0.0150
+25.00%
PTIX Protagenic Therapeutics, Inc.
0.5490
+10.91%
ALMS Alumis Inc.
8.50
+1.31%